Japanese Govt Takes Blame For HIV Spread

19 February 1996

Japan's Minister of Health and Welfare, Naoto Kan, has acknowledged that the government was responsible for HIV-infected blood products being put on the market during the 1980s and for these products infecting more than 1,800 people, nearly all of them hemophiliacs.

The Minister's acceptance of responsibility followed the discovery of nine 13-year-old files within the Ministry, containing information on research into AIDS. These show that, as far back as 1983 when the files were compiled by a Ministry study group, the government knew that it was possible to contract HIV infection through contaminated blood products. The files have been central to the demand for compensation filed by over 200 hemophiliacs, but the Ministry has always denied that they existed.

Mr Kan said that, having read the files, he could not now understand why the study group concluded in its final report that untreated blood products are safe. He also said that the compensation suits, which remain unsettled even though the first ones were brought to court in 1989, would be settled at an early date.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight